scispace - formally typeset
O

Oliver D. K. Maddocks

Researcher at University of Glasgow

Publications -  56
Citations -  5356

Oliver D. K. Maddocks is an academic researcher from University of Glasgow. The author has contributed to research in topics: Serine & Cancer cell. The author has an hindex of 21, co-authored 46 publications receiving 4031 citations. Previous affiliations of Oliver D. K. Maddocks include University of Edinburgh & Cancer Research UK.

Papers
More filters
Journal ArticleDOI

Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells

TL;DR: It is shown that human cancer cells rapidly use exogenous serine and that serine deprivation triggered activation of the serine synthesis pathway and rapidly suppressed aerobic glycolysis, resulting in an increased flux to the tricarboxylic acid cycle.
Journal ArticleDOI

Serine is a natural ligand and allosteric activator of pyruvate kinase M2

TL;DR: It is shown that serine can bind to and activate human PKM2, and thatPKM2 activity in cells is reduced in response to serine deprivation, which shifts cells to a fuel-efficient mode in which more pyruvate is diverted to the mitochondria and more glucose-derived carbon is channelled into serine biosynthesis to support cell proliferation.
Journal ArticleDOI

A roadmap for interpreting 13 C metabolite labeling patterns from cells

TL;DR: Key issues in interpreting (13)C metabolite labeling patterns are reviewed, with the goal of drawing accurate conclusions from steady state and dynamic stable isotopic tracer experiments.
Journal ArticleDOI

Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells.

TL;DR: It is concluded that nucleotide synthesis and cancer cell proliferation are supported by serine--rather than glycine--consumption, and therefore exogenous glycine cannot replace serine to supportcancer cell proliferation.
Journal ArticleDOI

Metabolic Regulation by p53 Family Members

TL;DR: A better understanding of the metabolic functions of p53 family members may aid in the identification of therapeutic targets and reveal novel uses for p53-modulating drugs.